Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

NCT00358670 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
441
Enrollment
INDUSTRY
Sponsor class

Stopped Infusion reactions during re-induction cycles after a period of no treatment. Please see "Purpose" section.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC